3 Weight Loss Mistakes Women Make on GLP-1 Drugs | Dr. Stacy Sims explains

Dr. Sims points out that historically, bariatric surgery patients were put on high protein diets because protein triggers GLP-1 release and satiety, yet today's GLP-1 users often receive no such concurrent advice. She warns that without strength training and adequate protein, the weight loss from GLP-1s is disproportionately muscle and bone, leaving individuals not just leaner but frailer. This protocol is her direct response to the missing 'green prescription' and should be considered part of the medical prescription, not an optional extra.

Drawing on the Biggest Loser example, she explains that even when contestants exercised after extreme weight loss, they regained weight because metabolic rate dropped and hunger signals intensified. She fears the same for GLP-1 users. The solution is not to remain on the drug indefinitely but to use the window of reduced food chatter to ingrain new behaviors. She praises certain obesity surgeons who take a holistic view, incorporating strength training, dietary psychology, and cardiovascular work. Until long-term data exist, behavioral change is the only safety net against rebound.

Dr. Sims describes this as 'a bit of a scary thing' where marketing is again stronger than science. She firmly rejects microdosing and also does not endorse using GLP-1s for minimal cosmetic weight loss (the '10 vanity pounds'). She sees a legitimate role for these drugs as a health intervention for those with severe weight issues, but not for unsubstantiated off-label tweaks. Her overall message is that without evidence, such practices are irresponsible and potentially harmful.

She recalls that before GLP-1 drugs became mainstream, bariatric patients were often prepared with high protein diets precisely because protein stimulates GLP-1 secretion and satiety, promoting weight loss. Today, however, there is no 'green prescription' — no required exercise or high-protein nutrition alongside the medication. The result is weight loss that disproportionately depletes muscle and bone, which she warns will 'end up with a very sarcopenic and sick leaner society.' She stresses that without intentional strength training and protein intake, people may become lighter but physically weaker, undermining healthspan.

She draws a direct parallel to The Biggest Loser, where despite participants maintaining exercise, their bodies rebounded due to metabolic adaptation. Her concern is that GLP-1 users, having lost weight quickly without developing sustainable habits, will experience a similar fate if they stop the medication. Therefore, she advocates that during the period of reduced food chatter, patients must embed strength training, cardiovascular exercise, and dietary trigger identification so that behavioral infrastructure is in place for long-term maintenance. She calls the current situation a 'population experiment' because the mass adoption of GLP-1s is unfolding without evidence on what happens after cessation.